Synapticure scores $25M to scale platform for neurodegenerative diseases
Synapticure, a telemedicine company focused on people and caregivers living with neurodegenerative diseases, announced it has raised $25 million in a Series A funding round led by B Capital. New investors CVS Health Ventures, RA…
Continue Reading